Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Whitehawk Therapeutics, Inc. | 569,643 | reported | 14 May 2026 | tx 17+2,416,061−85,537 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 May 2026 | GRANT_AWARD | Whitehawk Therapeutics, Inc. | 51,021 | 3.92 USD | |
| 01 Mar 2026 | EXERCISE | Whitehawk Therapeutics, Inc. | 16,250 | — | |
| 02 Mar 2026 | SALE | Whitehawk Therapeutics, Inc. | 5,100 | 3.31 USD | |
| 01 Mar 2026 | EXERCISE | Whitehawk Therapeutics, Inc. | 16,250 | 0.00 USD | deriv |
| 01 Apr 2025 | GRANT_AWARD | Whitehawk Therapeutics, Inc. | 775,828 | 0.00 USD | deriv |
| 01 Apr 2025 | GRANT_AWARD | Whitehawk Therapeutics, Inc. | 775,828 | 0.00 USD | deriv |
| 03 Mar 2025 | SALE | Whitehawk Therapeutics, Inc. | 5,690 | 2.35 USD | |
| 01 Mar 2025 | EXERCISE | Whitehawk Therapeutics, Inc. | 16,250 | — | |
| 01 Mar 2025 | EXERCISE | Whitehawk Therapeutics, Inc. | 16,250 | 0.00 USD | deriv |
| 03 Oct 2024 | SALE | Whitehawk Therapeutics, Inc. | 9,689 | 1.94 USD | |
| 02 Oct 2024 | EXERCISE | Whitehawk Therapeutics, Inc. | 32,558 | 0.00 USD | |
| 02 Oct 2024 | EXERCISE | Whitehawk Therapeutics, Inc. | 32,558 | 0.00 USD | deriv |
| 01 Mar 2024 | GRANT_AWARD | Whitehawk Therapeutics, Inc. | 65,000 | 0.00 USD | deriv |
| 01 Mar 2024 | GRANT_AWARD | Whitehawk Therapeutics, Inc. | 130,000 | 0.00 USD | deriv |
| 01 Mar 2024 | GRANT_AWARD | Whitehawk Therapeutics, Inc. | 30,768 | 0.00 USD | deriv |
| 02 Oct 2023 | GRANT_AWARD | Whitehawk Therapeutics, Inc. | 32,558 | 0.00 USD | deriv |
| 02 Oct 2023 | GRANT_AWARD | Whitehawk Therapeutics, Inc. | 490,000 | 0.00 USD | deriv |